BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lortholary O, Fernandez-Ruiz M, Baddley JW, Manuel O, Mariette X, Winthrop KL. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Ann Rheum Dis 2020;79:1532-43. [PMID: 32963049 DOI: 10.1136/annrheumdis-2020-217092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu Q, Zhong X, Tian H, Liao P. The Efficacy of Denosumab in Patients With Rheumatoid Arthritis: A Systematic Review and Pooled Analysis of Randomized or Matched Data. Front Immunol 2021;12:799575. [PMID: 35069583 DOI: 10.3389/fimmu.2021.799575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ordaya EE, Johnson JR, Drekonja DM, Niehans GE, Kaka AS. Aspergillus Osteomyelitis Secondary to Chronic Necrotizing Pulmonary Aspergillosis in a Patient With Rheumatoid Arthritis. Cureus 2021;13:e17774. [PMID: 34659985 DOI: 10.7759/cureus.17774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kido T, Shinoda K, Tobe K. A Case of Pulmonary Infarction Resembling Pneumonia during Immunosuppressive Treatment for Rheumatoid Arthritis. Case Rep Rheumatol 2021;2021:5983580. [PMID: 34457368 DOI: 10.1155/2021/5983580] [Reference Citation Analysis]
4 Kumar SK, Arya S, Singh A, Misra R, Aggarwal A, Sinha S. Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection. PLoS One 2021;16:e0255639. [PMID: 34339423 DOI: 10.1371/journal.pone.0255639] [Reference Citation Analysis]
5 Huang J, Zhang L, Wei JC. Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor? Int J Rheum Dis 2021;24:865-8. [PMID: 34241967 DOI: 10.1111/1756-185X.14076] [Reference Citation Analysis]
6 Hromadová D, Elewaut D, Inman RD, Strobl B, Gracey E. From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases. Front Genet 2021;12:685280. [PMID: 34290741 DOI: 10.3389/fgene.2021.685280] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Mateo L, Pedro-Botet ML, Esteve MG, Carrascosa JM; en representación del Comité de infecciones en paciente tratados con inmunosupresores selectivos del Hospital Germans Trias i Pujol. Contributions from a multidisciplinary committee for the prevention of infections in patients with targeted immunosuppressive therapy. Med Clin (Barc) 2021:S0025-7753(21)00244-X. [PMID: 34103165 DOI: 10.1016/j.medcli.2021.03.031] [Reference Citation Analysis]
8 Choong DJ, Tan E. Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations. Dermatol Ther 2021;34:e14990. [PMID: 34004074 DOI: 10.1111/dth.14990] [Reference Citation Analysis]
9 Vajdić ID, Štimac G, Pezelj I, Mustapić M, Grazio S. Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review. Rheumatol Int 2021;41:819-25. [PMID: 33576887 DOI: 10.1007/s00296-021-04800-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]